Home > Boards > US Listed > Biotechs > Can-Fite BioPharma (CANF)

"Improper co-ordination of trades by market makers creating

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
keekee Member Profile
 
Followed By 108
Posts 4,097
Boards Moderated 0
Alias Born 09/29/11
160x600 placeholder
Can-Fite to Present at H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021 Business Wire - 10/5/2021 7:00:00 AM
Can-Fite CEO to Join Benzinga Medical Cannabis Panel and Deliver Company Presentation at Healthcare Small Cap Conference on September 29, 2021 Business Wire - 9/22/2021 7:00:00 AM
Can-Fite to Participate in Three Upcoming Pharma Partnering Conferences Business Wire - 9/17/2021 7:00:00 AM
Can-Fite to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/9/2021 7:00:00 AM
Can-Fite Completes Patient Enrollment in Phase III Psoriasis Study Business Wire - 9/2/2021 7:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/2/2021 6:05:15 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/1/2021 4:31:26 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/1/2021 6:10:34 AM
Securities Registration (foreign Private Issuer) (f-1) Edgar (US Regulatory) - 8/26/2021 4:32:22 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 8/26/2021 4:31:32 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/26/2021 4:31:26 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/26/2021 7:29:41 AM
Can-Fite Reports Second Quarter 2021 Financial Results & Provides Clinical Update Business Wire - 8/26/2021 7:00:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/16/2021 10:22:37 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/13/2021 4:47:05 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/12/2021 8:13:43 AM
Can-Fite Announces $10.0 Million Registered Direct Offering Business Wire - 8/12/2021 8:00:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/5/2021 9:22:45 AM
Yossi Borenstein, CEO and Founder of Shizim Group, has been Elected to the Can-Fite Board Business Wire - 8/5/2021 9:18:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/29/2021 4:32:28 PM
Can-Fite set to begin enrollment in phase 3 liver cancer candidate study Seeking Alpha - 7/8/2021 8:11:03 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/8/2021 7:06:45 AM
Can-Fite Gears Up to Initiate Pivotal Phase III Liver Cancer Study Business Wire - 7/8/2021 7:00:00 AM
Can-Fite shares rise 8% on piclidenoson development deal for pets Seeking Alpha - 6/28/2021 7:35:35 AM
Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Picl... Business Wire - 6/28/2021 7:00:00 AM
keekee   Wednesday, 10/21/20 09:56:47 AM
Re: dsscam post# 1590
Post # of 1710 
"Improper co-ordination of trades by market makers creating a false or misleading appearance of trading activity in the Nasdaq market" This is violative of the antifraud provisions of the market.

This is exactly what we have going on in CANF. See our posts on TOPS too. MARKET MAKERS are criminally coordinating their trading in the stock and squaring each other. THIS IS CRIMINAL!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences